Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism MAPKs inhibitors(Mitogen-activated protein kinase inhibitors), NF-κB inhibitors(Nuclear factor NF-kappa-B complex inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H28O4 |
InChIKeyBCEKDLJRXSZZRB-RWQKAGTCSA-N |
CAS Registry62824-08-2 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colitis, Ulcerative | Preclinical | China | 03 Jul 2024 | |
| Colitis, Ulcerative | Preclinical | China | 03 Jul 2024 | |
| Colitis, Ulcerative | Preclinical | China | 03 Jul 2024 |





